These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19770476)

  • 1. Severe cardiac failure in a patient with multiple sclerosis following low-dose mitoxantrone treatment.
    Dörr J; Bitsch A; Schmailzl KJ; Chan A; von Ahsen N; Hummel M; Varon R; Lill CM; Vogel HP; Zipp F; Paul F
    Neurology; 2009 Sep; 73(12):991-3. PubMed ID: 19770476
    [No Abstract]   [Full Text] [Related]  

  • 2. Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case-control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium.
    Martino A; Campa D; Buda G; Sainz J; García-Sanz R; Jamroziak K; Reis RM; Weinhold N; Jurado M; Ríos R; Szemraj-Rogucka Z; Marques H; Szemraj J; Stein A; Kumar R; Orciuolo E; Gemignani F; Landi S; Goldschmidt H; Petrini M; Dumontet C; Canzian F; Rossi AM
    Leukemia; 2012 Jun; 26(6):1419-22. PubMed ID: 22182917
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacogenetics of ATP-binding cassette transporters and clinical implications.
    Cascorbi I; Haenisch S
    Methods Mol Biol; 2010; 596():95-121. PubMed ID: 19949922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
    Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
    Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe cardiac failure in a patient with multiple sclerosis following low-dose mitoxantrone treatment.
    Killestein J; van der Meer ML; Regelink JC; Huijgens PC; Polman CH
    Neurology; 2010 Mar; 74(11):934; author reply 934. PubMed ID: 20231672
    [No Abstract]   [Full Text] [Related]  

  • 6. The N-terminal pro-brain natriuretic peptide as a marker of mitoxantrone-induced cardiotoxicity in multiple sclerosis patients.
    Podlecka-Piętowska A; Kochanowski J; Zakrzewska-Pniewska B; Opolski G; Kwieciński H; Kamińska AM
    Neurol Neurochir Pol; 2014; 48(2):111-5. PubMed ID: 24821636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zafirlukast antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance.
    Sun YL; Kathawala RJ; Singh S; Zheng K; Talele TT; Jiang WQ; Chen ZS
    Anticancer Drugs; 2012 Sep; 23(8):865-73. PubMed ID: 22614107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2.
    Lepper ER; Nooter K; Verweij J; Acharya MR; Figg WD; Sparreboom A
    Pharmacogenomics; 2005 Mar; 6(2):115-38. PubMed ID: 15882131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitoxantrone treatment of multiple sclerosis: safety considerations.
    Pratt RG; Boehm GA; Kortepeter CM; Racoosin JA
    Neurology; 2005 Dec; 65(12):1997; author reply 1997. PubMed ID: 16380636
    [No Abstract]   [Full Text] [Related]  

  • 11. Dissecting sedation-induced delirium.
    Fraser GL; Worby CP; Riker RR
    Crit Care Med; 2013 Apr; 41(4):1144-6. PubMed ID: 23528763
    [No Abstract]   [Full Text] [Related]  

  • 12. Kinetic analysis of the cooperation of P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp/Abcg2) in limiting the brain and testis penetration of erlotinib, flavopiridol, and mitoxantrone.
    Kodaira H; Kusuhara H; Ushiki J; Fuse E; Sugiyama Y
    J Pharmacol Exp Ther; 2010 Jun; 333(3):788-96. PubMed ID: 20304939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predisposing to coma and delirium: fentanyl and midazolam exposure; CYP3A5, ABCB1, and ABCG2 genetic polymorphisms; and inflammatory factors.
    Skrobik Y; Leger C; Cossette M; Michaud V; Turgeon J
    Crit Care Med; 2013 Apr; 41(4):999-1008. PubMed ID: 23385102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometry-based assessment of mitoxantrone efflux from leukemic blasts varies with response to induction chemotherapy in acute myeloid leukemia.
    Kim HP; Bernard L; Berkowitz J; Nitta J; Hogge DE
    Cytometry B Clin Cytom; 2012 Sep; 82(5):283-94. PubMed ID: 22508650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of a pharmacogenetic approach using multiple candidate genes to predict response and resistance to imatinib therapy in chronic myeloid leukemia.
    Kim DH; Sriharsha L; Xu W; Kamel-Reid S; Liu X; Siminovitch K; Messner HA; Lipton JH
    Clin Cancer Res; 2009 Jul; 15(14):4750-8. PubMed ID: 19584153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain natriuretic peptide as a marker of cardiac toxicity in patients with multiple sclerosis treated with mitoxantrone.
    Bertora P; Torzillo D; Baldi G; Vago T; Mariani C
    J Neurol; 2008 Jan; 255(1):140-1. PubMed ID: 18004637
    [No Abstract]   [Full Text] [Related]  

  • 17. A comprehensive study of polymorphisms in ABCB1, ABCC2 and ABCG2 and lung cancer chemotherapy response and prognosis.
    Campa D; Müller P; Edler L; Knoefel L; Barale R; Heussel CP; Thomas M; Canzian F; Risch A
    Int J Cancer; 2012 Dec; 131(12):2920-8. PubMed ID: 22473764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polymorphism of ABCB1 and ABCG2 genes encoding drug transporters and their investigation by pyrosequencing].
    Dribnokhodova OP; Mironov KO; Dunaeva EA; Shipulin GA
    Eksp Klin Farmakol; 2012; 75(10):29-36. PubMed ID: 23240156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic interaction of ABCB1 and ABCG2 polymorphisms predicts the prevalence of toxic encephalopathy during anticancer chemotherapy.
    Erdilyi DJ; Kámory E; Csókay B; Andrikovics H; Tordai A; Kiss C; Filni-Semsei A; Janszky I; Zalka A; Fekete G; Falus A; Kovács GT; Szalai C
    Pharmacogenomics J; 2008 Oct; 8(5):321-7. PubMed ID: 17938643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug distribution, resistance to cytostatics and disease pathogenesis: many roles of ABC proteins].
    Lehmann S; Rane A
    Lakartidningen; 2004 Jan; 101(4):282-7. PubMed ID: 14979001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.